179 related articles for article (PubMed ID: 9694943)
1. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T
J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943
[TBL] [Abstract][Full Text] [Related]
2. Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
Hiranuma T; Iwao K; Kitamura K; Matsumiya T; Oka T
J Pharmacol Exp Ther; 1997 May; 281(2):769-74. PubMed ID: 9152384
[TBL] [Abstract][Full Text] [Related]
3. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides.
Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of dynorphin-(1-8) in isolated preparations by three peptidases.
Numata H; Hiranuma T; Oka T
Jpn J Pharmacol; 1988 Aug; 47(4):417-23. PubMed ID: 2903264
[TBL] [Abstract][Full Text] [Related]
5. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan.
Hiranuma T; Oka T
Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of [Leu5]-enkephalin in three isolated preparations: relative importance of aminopeptidase, endopeptidase-24.11 and peptidyl dipeptidase A.
Oka T; Aoki K; Kajiwara M; Ishii K; Kuno Y; Hiranuma T; Matsumiya T
NIDA Res Monogr; 1986; 75():259-62. PubMed ID: 2828976
[TBL] [Abstract][Full Text] [Related]
7. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
8. Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1-8) in rats.
Kitamura K; Akahori K; Yano H; Iwao K; Oka T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):273-8. PubMed ID: 10731039
[TBL] [Abstract][Full Text] [Related]
9. The enhancing effects of amastatin, phosphoramidon and captopril on the potency of [Met5]-enkephalin in rat vas deferens.
Cui SY; Kajiwara M; Ishii K; Aoki K; Sakamoto J; Matsumiya T; Oka T
Jpn J Pharmacol; 1986 Sep; 42(1):43-9. PubMed ID: 3540390
[TBL] [Abstract][Full Text] [Related]
10. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
Song B; Marvizón JC
J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189
[TBL] [Abstract][Full Text] [Related]
11. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
Dumont M; Lemaire S
J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
[TBL] [Abstract][Full Text] [Related]
12. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
Schulz R; Wüster M; Herz A
J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
[TBL] [Abstract][Full Text] [Related]
13. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
[TBL] [Abstract][Full Text] [Related]
14. Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat.
Ajimi J; Yoshikawa M; Takahashi S; Miura M; Tsukamoto H; Kawaguchi M; Kobayashi H; Suzuki T
J Anesth; 2015 Feb; 29(1):65-77. PubMed ID: 24943455
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of [Met5]enkephalin semicarbazide is not affected by dipeptidyl carboxypeptidase-I.
Rezaee Z; Arabanian SA; Balalaie S; Ahmadiani A; Khalaj L; Nasoohi S
J Pept Sci; 2012 Feb; 18(2):92-6. PubMed ID: 22083687
[TBL] [Abstract][Full Text] [Related]
16. [Enkephalin-inactivating enzymes].
Oka T; Hiranuma T; Liu XF; Ohgiya N; Iwao K; Matsumiya T
Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):197-207. PubMed ID: 8390390
[TBL] [Abstract][Full Text] [Related]
17. Great increase in antinociceptive potency of [Leu5]enkephalin after peptidase inhibition.
Akahori K; Kosaka K; Jin XL; Arai Y; Yoshikawa M; Kobayashi H; Oka T
J Pharmacol Sci; 2008 Feb; 106(2):295-300. PubMed ID: 18296865
[TBL] [Abstract][Full Text] [Related]
18. Estimation of relative importance of three enzymes in the inactivation of [Met5]-enkephalin and [Met5]-enkephalin-Arg6 in three isolated preparations by employing the inhibitor specific for each enzyme.
Kuno Y; Oka T
Jpn J Pharmacol; 1987 Jul; 44(3):241-7. PubMed ID: 2821306
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
20. Identification of synaptic metabolites of dynorphin A (1-8) by electrospray ionization and tandem mass spectrometry.
Prokai L; Zharikova AD
Rapid Commun Mass Spectrom; 1998; 12(22):1796-800. PubMed ID: 9853388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
